Acute myeloid leukemia remodels endosteal vascular niche into a leukemic niche.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

5 citing papers in PubMed.

1. Bone marrow endosteum in homeostasis and metastasis.Open biology · 2025
   Review
2. The Dynamic Interface Between the Bone Marrow Vascular Niche and Hematopoietic Stem Cells in Myeloid Malignancy.Frontiers in cell and developmental biology · 2021
   Review
3. Deciphering the Therapeutic Resistance in Acute Myeloid Leukemia.International journal of molecular sciences · 2020
   Review
4. Development of a highly sensitive method for detection of FLT3D835Y.Biomarker research · 2020
   Article
5. Targeting Leukemia Stem Cell-Niche Dynamics: A New Challenge in AML Treatment.Journal of oncology · 2019
   Review

Corrections and comments

• Comment on
  Inhibition of Endosteal Vascular Niche Remodeling Rescues Hematopoietic Stem Cell Loss in AML.2018

Authors and funding

2 authors.

Funding

Abstract

PubMed holds no abstract for this paper.